The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 10, 2017
Filed:
Jan. 08, 2015
Applicants:
Novartis Ag, Basel, CH;
Xoma Technology Ltd., Berkeley, CA (US);
Inventors:
Linda Masat, Walnut Creek, CA (US);
Jeff Hsu, Pinole, CA (US);
Assignees:
NOVARTIS AG, Basel, CH;
XOMA TECHNOLOGY LTD., Berkeley, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C12P 21/08 (2006.01); F02C 7/20 (2006.01); F02K 1/80 (2006.01); F02K 3/10 (2006.01); F16B 35/04 (2006.01); F01D 25/16 (2006.01); F16B 33/00 (2006.01); F16B 43/00 (2006.01);
U.S. Cl.
CPC ...
F02C 7/20 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); C07K 16/18 (2013.01); C07K 16/28 (2013.01); F01D 25/162 (2013.01); F02K 1/80 (2013.01); F02K 3/10 (2013.01); F16B 35/048 (2013.01); F05D 2260/31 (2013.01); F16B 33/002 (2013.01); F16B 43/001 (2013.01);
Abstract
EphB3-specific antibodies are provided, along with pharmaceutical compositions containing such antibody, kits containing a pharmaceutical composition, and methods of preventing and treating an EphB3-related disease or disorder.